iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3028% below fair value

$0.71−0.03 (-3.81%)

Close on Nov 11, 2026Market cap $1.79MP/E –Yield –

iSpecimen operating margin

Operating margin is operating income as a percentage of revenue.

iSpecimen's operating margin for the twelve months ending Jun 30, 2026 was -2020.0%. For fiscal 2025 it was -465.4%, against -137.0% the year before. The highest annual figure on record is -29.4% in fiscal 2020.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-465.4%	−328.4
FY2024	Dec 31, 2024	-137.0%	−24.5
FY2023	Dec 31, 2023	-112.5%	−14.6
FY2022	Dec 31, 2022	-97.9%	−44.7
FY2021	Dec 31, 2021	-53.2%	−23.8
FY2020	Dec 31, 2020	-29.4%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	-897.1%	−641.6
Q1 FY2026	Mar 31, 2026	-1627.1%	−1472.2
Q4 FY2025	Dec 31, 2025	-5192.9%	−4797.0
Q3 FY2025	Sep 30, 2025	-2655.2%	−2591.1
Q2 FY2025	Jun 30, 2025	-255.4%	−179.2
Q1 FY2025	Mar 31, 2025	-154.9%	−23.9
Q4 FY2024	Dec 31, 2024	-395.8%	−284.3
Q3 FY2024	Sep 30, 2024	-64.1%	+14.9
Q2 FY2024	Jun 30, 2024	-76.2%	+143.0
Q1 FY2024	Mar 31, 2024	-131.0%	−44.8
Q4 FY2023	Dec 31, 2023	-111.5%	−39.2
Q3 FY2023	Sep 30, 2023	-79.0%	+41.0
Q2 FY2023	Jun 30, 2023	-219.2%	−108.6
Q1 FY2023	Mar 31, 2023	-86.2%	+7.5
Q4 FY2022	Dec 31, 2022	-72.3%	+5.9
Q3 FY2022	Sep 30, 2022	-120.0%	−66.4
Q2 FY2022	Jun 30, 2022	-110.5%	−57.9
Q1 FY2022	Mar 31, 2022	-93.6%	−61.8
Q4 FY2021	Dec 31, 2021	-78.3%	−43.9
Q3 FY2021	Sep 30, 2021	-53.7%	−21.5
Q2 FY2021	Jun 30, 2021	-52.6%	−32.4
Q1 FY2021	Mar 31, 2021	-31.8%	–
Q4 FY2020	Dec 31, 2020	-34.4%	–
Q3 FY2020	Sep 30, 2020	-32.1%	–
Q2 FY2020	Jun 30, 2020	-20.3%	–